SURPASSing Therapeutic Challenges of Paediatric Type 2 Diabetes with Tirzepatide

Watch the full video on YouTube to learn more about the SURPASS-PEDS trial and the first use of a dual GIP/GLP-1 agonist in adolescents with type 2 diabetes. Explore background research on youth-onset type 2 diabetes, including rising incidence, weight-gain velocity, and metabolic progression.

Explore the latest EASD 2025 Annual Meeting presentations and view our speakers’ profiles:

1. Dr Tamara Hannon - University of Indiana, paediatric endocrinologist and SURPASS-PEDS trial investigator
2. Dr Martin Wabitsch - Universitätsklinikum Ulm, paediatric obesity and diabetes specialist

For more content from our previous episodes, visit our podcast archive.